Motoko Yamaguchi Selected Research

Motoko Yamaguchi Research Topics

Disease

21	Lymphoma (Lymphomas) 03/2022 - 01/2003
13	T-Cell Lymphoma (Lymphoma, T Cell) 07/2021 - 01/2003
13	Neoplasms (Cancer) 11/2018 - 01/2003
7	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 04/2004
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2021 - 08/2002
5	Extranodal NK-T-Cell Lymphoma 10/2022 - 05/2010
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2018 - 08/2002
2	Disease Progression 06/2018 - 12/2017
2	Leukopenia 08/2012 - 04/2010
2	Liver Diseases (Liver Disease) 04/2010 - 01/2009
2	Thrombocytopenia (Thrombopenia) 04/2010 - 01/2007
2	Large Granular Lymphocytic Leukemia 04/2010 - 05/2008
2	Disseminated Intravascular Coagulation 01/2006 - 01/2005
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2004 - 01/2003
1	Cognitive Dysfunction 07/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2020
1	Atypical Hemolytic Uremic Syndrome 01/2018
1	Neutropenia 08/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2011
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 05/2010
1	Multiple Myeloma 04/2009
1	Plasmacytoma 04/2009
1	Leukemia 05/2008
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2008
1	Infections 01/2006
1	Thrombosis (Thrombus) 01/2006
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2006
1	Neoplasm Metastasis (Metastasis) 03/2005
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2005
1	Pleural Empyema (Pyothorax) 04/2004

Drug/Important Bio-Agent (IBA)

10	Rituximab (Mabthera)FDA Link 07/2021 - 07/2008
6	Methotrexate (Mexate)FDA LinkGeneric 07/2021 - 05/2008
6	Vincristine (Oncovin)FDA LinkGeneric 07/2021 - 10/2011
6	Etoposide (VP 16)FDA LinkGeneric 12/2020 - 03/2005
5	AnthracyclinesIBA 10/2022 - 01/2007
5	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 10/2011
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2020 - 10/2011
4	Asparaginase (Elspar)FDA Link 11/2020 - 05/2008
4	Ifosfamide FDA LinkGeneric 08/2012 - 03/2005
3	Prednisone (Sone)FDA LinkGeneric 05/2020 - 10/2011
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2011 - 03/2005
2	Prednisolone (Predate)FDA LinkGeneric 12/2020 - 01/2020
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2018 - 10/2011
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2017 - 05/2008
2	SteroidsIBA 08/2012 - 11/2011
2	DNA (Deoxyribonucleic Acid)IBA 08/2012 - 12/2011
2	Proteins (Proteins, Gene)FDA Link 08/2008 - 01/2003
2	Thromboplastin (Tissue Factor)IBA 01/2006 - 01/2005
2	Messenger RNA (mRNA)IBA 01/2006 - 01/2005
2	Dacarbazine (DIC)FDA LinkGeneric 01/2006 - 01/2005
2	fibrin fragment D (D-dimer)IBA 01/2006 - 01/2005
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2005 - 08/2002
2	Integrin beta1IBA 03/2004 - 01/2003
1	polatuzumab vedotinIBA 07/2021
1	Bendamustine Hydrochloride FDA Link 07/2021
1	Procarbazine (Matulane)FDA Link 07/2021
1	Cytochrome P-450 CYP3AIBA 05/2020
1	R-CHOP protocolIBA 05/2020
1	Dihydrotachysterol (AT 10)IBA 11/2018
1	eculizumab FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 11/2014
1	Indicators and Reagents (Reagents)IBA 12/2011
1	purineIBA 02/2011
1	Cladribine FDA LinkGeneric 02/2011
1	AlbuminsIBA 05/2010
1	Blood Proteins (Serum Proteins)IBA 05/2010
1	HLA-DR Antigens (HLA-DR)IBA 04/2010
1	Ferritins (Ferritin)IBA 04/2010
1	C-Reactive ProteinIBA 01/2006
1	FibrinIBA 01/2006
1	Hemostatics (Antihemorrhagics)IBA 01/2006
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2006
1	SHU 508 (Levovist)IBA 01/2006
1	Hemoglobins (Hemoglobin)IBA 06/2005
1	T-Cell Intracellular Antigen-1IBA 03/2005
1	Carboplatin (JM8)FDA LinkGeneric 03/2005
1	Thomsen-Friedenreich antigenIBA 01/2005
1	Fibrinogen (Factor I)FDA Link 01/2005
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2005
1	formycin diphosphate (FDP)IBA 01/2005
1	CytokinesIBA 01/2005
1	von Willebrand FactorIBA 01/2005
1	RNA (Ribonucleic Acid)IBA 04/2004
1	AntigensIBA 04/2004
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 04/2004
1	Cyclin D1IBA 03/2004
1	Death-Associated Protein KinasesIBA 01/2003

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 11/2020 - 09/2005
14	Therapeutics 10/2022 - 04/2004
7	Chemoradiotherapy 06/2018 - 11/2009
4	Radiotherapy 07/2021 - 03/2005
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2010 - 09/2005
2	Transplantation 03/2022 - 07/2021
2	Stem Cell Transplantation 07/2021 - 04/2009
1	Aftercare (After-Treatment) 11/2018
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2018
1	Salvage Therapy 02/2011
1	Combination Drug Therapy (Combination Chemotherapy) 03/2005
1	Endoscopes 03/2005